04/12/2024
4:59 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:10 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:58 PM | Sutro Biopharma (Filer)
| Form 424B5 | |
04/02/2024
5:04 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
3:28 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4/A | |
03/07/2024
6:12 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/07/2024
3:26 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:28 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:31 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:32 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:18 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:21 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:40 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:29 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:15 PM | Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:33 PM | Sutro Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2024
11:16 AM | Sutro Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
02/09/2024
3:27 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
6:56 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
01/31/2024
3:23 PM | Sutro Biopharma (Issuer)
Vasquez Nicki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:28 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:29 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:54 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G | |
01/08/2024
6:31 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
3:19 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
11:15 PM | Sutro Biopharma (Filer)
| Form EFFECT | |
11/21/2023
3:05 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
4:18 PM | Sutro Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2023
3:30 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:32 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023
3:52 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G | |
10/04/2023
3:31 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:19 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:15 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/29/2023
3:40 PM | Shtylla Brunilda (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
3:18 PM | Shtylla Brunilda (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:46 PM | Shtylla Brunilda (Reporting)
Sutro Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023
5:40 PM | Sutro Biopharma (Issuer)
Vasquez Nicki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
06/29/2023
5:28 PM | Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
7:01 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:31 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
5:51 PM | Hunter Heidi (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:30 PM | Dybbs Michael (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:32 PM | Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:37 PM | Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:38 PM | MATSUI CONNIE (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:38 PM | PANEK JAMES P (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:39 PM | Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:40 PM | Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
7:01 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
7:05 AM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2023
5:51 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
5:26 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/28/2023
3:10 PM | Sutro Biopharma (Filer)
| Form ARS | |
